{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:01Z","timestamp":1790279941822,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03430-6","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:45:12Z","timestamp":1780602312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Chitosan-Poloxamer Nanoparticles and Poloxamer-based In-Situ Forming Gel for Nose-to-Brain Delivery of Cetrorelix: In Vitro and Pharmacokinetic Studies in Rats"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-6915","authenticated-orcid":false,"given":"Soheil Tafazzoli","family":"Mehrjardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-0973","authenticated-orcid":false,"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-4326","authenticated-orcid":false,"given":"Davood","family":"Yari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-0861","authenticated-orcid":false,"given":"Hossein","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-2482","authenticated-orcid":false,"given":"Ali","family":"Nokhodchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"1","key":"3430_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","volume":"53","author":"S-H Jeong","year":"2023","unstructured":"Jeong S-H, Jang J-H, Lee Y-B. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig. 2023;53(1):119\u201352.","journal-title":"J Pharm Investig"},{"issue":"1","key":"3430_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ar.10047","volume":"269","author":"JE Schwob","year":"2002","unstructured":"Schwob JE. Neural regeneration and the peripheral olfactory system. Anat Rec. 2002;269(1):33\u201349.","journal-title":"Anat Rec"},{"issue":"7","key":"3430_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071999","volume":"15","author":"SM Ghorai","year":"2023","unstructured":"Ghorai SM, Deep A, Magoo D, Gupta C, Gupta N. Cell-penetrating and targeted peptides delivery systems as potential pharmaceutical carriers for enhanced delivery across the blood\u2013brain barrier (BBB). Pharmaceutics. 2023;15(7).","journal-title":"Pharmaceutics"},{"issue":"3","key":"3430_CR4","first-page":"203","volume":"5","author":"H Kumar","year":"2017","unstructured":"Kumar H, Mishra G, Sharma AK, Gothwal A, Kesharwani P, Gupta U. Intranasal drug delivery: a non-invasive approach for the better delivery of neurotherapeutics. Pharm Nanotechnol. 2017;5(3):203\u201314.","journal-title":"Pharm Nanotechnol"},{"issue":"7","key":"3430_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4155\/tde-2016-0022","volume":"7","author":"RU Agu","year":"2016","unstructured":"Agu RU. Challenges in nasal drug absorption: how far have we come? Ther Deliv. 2016;7(7):495\u2013510.","journal-title":"Ther Deliv"},{"key":"3430_CR6","doi-asserted-by":"crossref","unstructured":"Alturi H, Tirucherai GS, Dias CS, Patel J, Mitra AK. Ocular, Nasal, Pulmonary, and Otic Routes of Drug Delivery. Theory and Practice of Contemporary Pharmaceutics: CRC Press; 2021. p. 479\u2013524.","DOI":"10.1201\/9780203644478-20"},{"issue":"1","key":"3430_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/tra.12533","volume":"19","author":"KY Fung","year":"2018","unstructured":"Fung KY, Fairn GD, Lee WL. Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities. Traffic. 2018;19(1):5\u201318.","journal-title":"Traffic"},{"issue":"11","key":"3430_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110598","volume":"11","author":"JJ Lochhead","year":"2019","unstructured":"Lochhead JJ, Davis TP. Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration. Pharmaceutics. 2019;11(11).","journal-title":"Pharmaceutics"},{"issue":"1","key":"3430_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","volume":"11","author":"L Illum","year":"2000","unstructured":"Illum L. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 2000;11(1):1\u201318.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3430_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030116","volume":"10","author":"S G\u00e4nger","year":"2018","unstructured":"G\u00e4nger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 2018;10(3).","journal-title":"Pharmaceutics"},{"issue":"5","key":"3430_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051557","volume":"15","author":"M Usman Khan","year":"2023","unstructured":"Usman Khan M, Cai X, Shen Z, Mekonnen T, Kourmatzis A, Cheng S, et al. Challenges in the development and application of organ-on-chips for intranasal drug delivery studies. Pharmaceutics. 2023;15(5).","journal-title":"Pharmaceutics"},{"key":"3430_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2022.05.002","volume":"176","author":"P Henriques","year":"2022","unstructured":"Henriques P, Fortuna A, Doktorovov\u00e1 S. Spray dried powders for nasal delivery: process and formulation considerations. Eur J Pharm Biopharm. 2022;176:1\u201320.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"3430_CR13","first-page":"140","volume":"36","author":"S Talegaonkar","year":"2004","unstructured":"Talegaonkar S, Mishra P. Intranasal delivery: an approach to bypass the blood brain barrier. Indian J Pharmacol. 2004;36(3):140\u20137.","journal-title":"Indian J Pharmacol"},{"key":"3430_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.addr.2017.09.020","volume":"124","author":"F Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo F, Martins C, Azevedo C, Sarmento B. Chemical modification of drug molecules as strategy to reduce interactions with mucus. Adv Drug Deliv Rev. 2018;124:98\u2013106.","journal-title":"Adv Drug Deliv Rev"},{"key":"3430_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2022.105230","volume":"145","author":"N Wickramasuriya","year":"2022","unstructured":"Wickramasuriya N, Hawkins R, Atwood C, Butler T. The roles of GnRH in the human central nervous system. Horm Behav. 2022;145.","journal-title":"Horm Behav"},{"key":"3430_CR16","first-page":"103","volume-title":"Hormonal delivery systems","author":"SR Paliwal","year":"2024","unstructured":"Paliwal SR, Sulakhiya K, Kumar P, Maiti S, Paliwal R. Hormonal delivery systems. Molecular Pharmaceutics and Nano Drug Delivery: Elsevier; 2024. p. 103\u201334."},{"key":"3430_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2021.170716","volume":"150","author":"R Cai","year":"2022","unstructured":"Cai R, Zhang X, Wang H, Cui T, Halmos G, Sha W, et al. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides. 2022;150.","journal-title":"Peptides"},{"key":"3430_CR18","unstructured":"Noll DJ. Modified ovarian stimulation protocols for patients with BRCA1\/BRCA2\/TP53 mutations and their impact on the outcome of the ART procedure. 2024."},{"key":"3430_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017;268:364\u201389.","journal-title":"J Control Release"},{"issue":"8","key":"3430_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","volume":"24","author":"KA Soliman","year":"2019","unstructured":"Soliman KA, Ullah K, Shah A, Jones DS, Singh TR. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Drug Discov Today. 2019;24(8):1575\u201386.","journal-title":"Drug Discov Today"},{"issue":"3","key":"3430_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","volume":"66","author":"DA Chiappetta","year":"2007","unstructured":"Chiappetta DA, Sosnik A. Poly (ethylene oxide)\u2013poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66(3):303\u201317.","journal-title":"Eur J Pharm Biopharm"},{"key":"3430_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1208\/s12249-010-9477-x","volume":"11","author":"S Basu","year":"2010","unstructured":"Basu S, Bandyopadhyay AK. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech. 2010;11:1223\u201331.","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"3430_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","volume":"48","author":"S Pund","year":"2013","unstructured":"Pund S, Rasve G, Borade G. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci. 2013;48(1\u20132):195\u2013201.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3430_CR24","first-page":"711","volume":"71","author":"A Bhalerao","year":"2009","unstructured":"Bhalerao A, Lonkar S, Deshkar S, Shirolkar S, Deshpande A. Nasal mucoadhesive in situ gel of ondansetron hydrochloride. Indian J Pharm Sci. 2009;71(6):711.","journal-title":"Indian J Pharm Sci"},{"issue":"8","key":"3430_CR25","first-page":"38","volume":"2","author":"SD Badgujar","year":"2010","unstructured":"Badgujar SD, Sontakke MA, Narute DR, Karmarkar RR, Tupkar S, Barhate S. Formulation and evaluation of sumatriptan succinate nasal in situ gel using fulvic acid as novel permeation enhancer. Int J Pharm Res Dev. 2010;2(8):38\u201352.","journal-title":"Int J Pharm Res Dev"},{"issue":"1","key":"3430_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","volume":"21","author":"C Karavasili","year":"2016","unstructured":"Karavasili C, Fatouros DG. Smart materials: in situ gel-forming systems for nasal delivery. Drug Discov Today. 2016;21(1):157\u201366.","journal-title":"Drug Discov Today"},{"issue":"4","key":"3430_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3109\/21691401.2015.1012260","volume":"44","author":"P Kaur","year":"2016","unstructured":"Kaur P, Garg T, Rath G, Goyal AK. In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol. 2016;44(4):1167\u201376.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"7","key":"3430_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jps.10397","volume":"92","author":"ML Adams","year":"2003","unstructured":"Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003;92(7):1343\u201355.","journal-title":"J Pharm Sci"},{"key":"3430_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.colsurfa.2018.09.074","volume":"559","author":"SA Pillai","year":"2018","unstructured":"Pillai SA, Patel VI, Ray D, Pal H, Aswal VK, Bahadur P. Solubilization and interaction of cinnamic acid and its analogues with Pluronic\u00ae micelles. Colloids Surf A Physicochem Eng Asp. 2018;559:314\u201324.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"6","key":"3430_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/1061186X.2017.1289538","volume":"25","author":"L-Y Zhao","year":"2017","unstructured":"Zhao L-Y, Zhang W-M. Recent progress in drug delivery of pluronic P123: pharmaceutical perspectives. J Drug Target. 2017;25(6):471\u201384.","journal-title":"J Drug Target"},{"key":"3430_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","volume":"209","author":"MSH Akash","year":"2015","unstructured":"Akash MSH, Rehman K. Recent progress in biomedical applications of pluronic (PF127): pharmaceutical perspectives. J Control Release. 2015;209:120\u201338.","journal-title":"J Control Release"},{"issue":"25","key":"3430_CR32","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1021\/ma0008544","volume":"33","author":"JD Pruitt","year":"2000","unstructured":"Pruitt JD, Husseini G, Rapoport N, Pitt WG. Stabilization of pluronic P-105 micelles with an interpenetrating network of N, N-diethylacrylamide. Macromolecules. 2000;33(25):9306\u20139.","journal-title":"Macromolecules"},{"issue":"1","key":"3430_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2007.10.024","volume":"63","author":"KM Park","year":"2008","unstructured":"Park KM, Bae JW, Joung YK, Shin JW, Park KD. Nanoaggregate of thermosensitive chitosan-pluronic for sustained release of hydrophobic drug. Colloids Surf B Biointerfaces. 2008;63(1):1\u20136.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3430_CR34","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S26365","author":"H Hosseinzadeh","year":"2012","unstructured":"Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN. Chitosan\u2013pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine. 2012. https:\/\/doi.org\/10.2147\/IJN.S26365.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3430_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/593878","volume":"2012","author":"C Manaspon","year":"2012","unstructured":"Manaspon C, Viravaidya-Pasuwat K, Pimpha N. Preparation of folate-conjugated pluronic F127\/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J Nanomater. 2012;2012(1).","journal-title":"J Nanomater"},{"issue":"2","key":"3430_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.actbio.2013.10.020","volume":"10","author":"W Rao","year":"2014","unstructured":"Rao W, Zhang W, Poventud-Fuentes I, Wang Y, Lei Y, Agarwal P, et al. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomater. 2014;10(2):831\u201342.","journal-title":"Acta Biomater"},{"issue":"1-2","key":"3430_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0168-3659(00)00340-0","volume":"70","author":"HS Yoo","year":"2001","unstructured":"Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA\u2013PEG block copolymer. J Control Release. 2001;70(1\u20132):63\u201370.","journal-title":"J Control Release"},{"issue":"5-6","key":"3430_CR38","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ten.2005.11.974","volume":"11","author":"SF Khattak","year":"2005","unstructured":"Khattak SF, Bhatia SR, Roberts SC. Pluronic F127 as a cell encapsulation material: utilization of membrane-stabilizing agents. Tissue Eng. 2005;11(5\u20136):974\u201383.","journal-title":"Tissue Eng"},{"issue":"6","key":"3430_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1515\/tsd-2023-2542","volume":"60","author":"S Agni","year":"2023","unstructured":"Agni S, Jose J, Ugare SR, Kumar L, Khot KB. Design, characterization, and evaluation of novel mucoadhesive nasal inserts for the treatment of hypertension. Tenside Surfactants Deterg. 2023;60(6):599\u2013610.","journal-title":"Tenside Surfactants Deterg"},{"issue":"1","key":"3430_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1122\/1.4971992","volume":"61","author":"M Jalaal","year":"2017","unstructured":"Jalaal M, Cottrell G, Balmforth N, Stoeber B. On the rheology of Pluronic F127 aqueous solutions. J Rheol. 2017;61(1):139\u201346.","journal-title":"J Rheol"},{"issue":"3","key":"3430_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/bm0156431","volume":"3","author":"Y-M Chung","year":"2002","unstructured":"Chung Y-M, Simmons KL, Gutowska A, Jeong B. Sol\u2212 gel transition temperature of PLGA-g-PEG aqueous solutions. Biomacromolecules. 2002;3(3):511\u20136.","journal-title":"Biomacromolecules"},{"issue":"8","key":"3430_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0014-3057(03)00068-5","volume":"39","author":"C Zhang","year":"2003","unstructured":"Zhang C, Ping Q, Zhang H, Shen J. Synthesis and characterization of water-soluble O-succinyl-chitosan. Eur Polym J. 2003;39(8):1629\u201334.","journal-title":"Eur Polym J"},{"issue":"10","key":"3430_CR43","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1021\/acs.biomac.9b00842","volume":"20","author":"H Choi","year":"2019","unstructured":"Choi H, Choi W, Kim J, Kong WH, Kim KS, Kim C, et al. Multifunctional nanodroplets encapsulating naphthalocyanine and perfluorohexane for bimodal image-guided therapy. Biomacromol. 2019;20(10):3767\u201377.","journal-title":"Biomacromol"},{"issue":"11","key":"3430_CR44","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1021\/nn101617n","volume":"4","author":"W Zhang","year":"2010","unstructured":"Zhang W, Gilstrap K, Wu L, Kc RB, Moss MA, Wang Q, et al. Synthesis and characterization of thermally responsive pluronic F127\u2212 chitosan nanocapsules for controlled release and intracellular delivery of small molecules. ACS Nano. 2010;4(11):6747\u201359.","journal-title":"ACS Nano"},{"issue":"19","key":"3430_CR45","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/jssc.201200251","volume":"35","author":"M Hardt-Stremayr","year":"2012","unstructured":"Hardt-Stremayr M, Bernaskova M, Hauser S, Kunert O, Guo X, Stephan J, et al. Development and validation of an HPLC method to determine metabolites of 5-hydroxymethylfurfural (5-HMF). J Sep Sci. 2012;35(19):2567\u201374.","journal-title":"J Sep Sci"},{"issue":"4","key":"3430_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejps.2006.03.005","volume":"28","author":"A Akhgari","year":"2006","unstructured":"Akhgari A, Farahmand F, Afrasiabi Garekani H, Sadeghi F, Vandamme TF. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur J Pharm Sci. 2006;28(4):307\u201314. https:\/\/doi.org\/10.1016\/j.ejps.2006.03.005.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3430_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-024-05985-6","volume":"26","author":"PSA Chakravarthy","year":"2024","unstructured":"Chakravarthy PSA, Popli P, Challa RR, Vallamkonda B, Singh I, Swami R. Bile salts: unlocking the potential as bio-surfactant for enhanced drug absorption. J Nanopart Res. 2024;26(4).","journal-title":"J Nanopart Res"},{"issue":"3","key":"3430_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Xie S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99(3):306\u201314.","journal-title":"Comput Methods Programs Biomed"},{"key":"3430_CR49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","volume":"189","author":"L Kozlovskaya","year":"2014","unstructured":"Kozlovskaya L, Abou-Kaoud M, Stepensky D. Quantitative analysis of drug delivery to the brain via nasal route. J Control Release. 2014;189:133\u201340.","journal-title":"J Control Release"},{"key":"3430_CR50","doi-asserted-by":"crossref","unstructured":"Rignall A. ICHQ1A (R2) stability testing of new drug substance and product and ICHQ1C stability testing of new dosage forms. 2017.","DOI":"10.1002\/9781118971147.ch1"},{"key":"3430_CR51","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s198552","author":"P Naruphontjirakul","year":"2019","unstructured":"Naruphontjirakul P, Viravaidya-Pasuwat K. Development of anti-HER2-targeted doxorubicin\u2013core-shell chitosan nanoparticles for the treatment of human breast cancer. Int J Nanomedicine. 2019. https:\/\/doi.org\/10.2147\/ijn.s198552.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"3430_CR52","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03169-6","volume":"26","author":"S Tafazzoli Mehrjardi","year":"2025","unstructured":"Tafazzoli Mehrjardi S, Tafaghodi M, Malek S, Yari D, Mohammadpour AH, Kamali H, et al. Intranasal delivery of cetrorelix via lipid liquid crystal nanoparticles: characterization and pharmacokinetic studies in rats. AAPS PharmSciTech. 2025;26(6).","journal-title":"AAPS PharmSciTech"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03430-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03430-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:04:00Z","timestamp":1790276640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03430-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["3430"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03430-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Mashhad University of Medical Sciences (IR.MUMS.PHARMACY.REC.1399.037).","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"226"}}